Ardsley Advisory Partners LP Acer Therapeutics Inc. Transaction History

Ardsley Advisory Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$3.45 - $26.86 $62,100 - $483,480	-18,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$20.4 - $25.15 $40,800 - $50,300	-2,000 Reduced 10.0%	18,000 $437,000
Q1 2018 May 15, 2018	BUY	$14.81 - $20.22 $69,607 - $95,034	4,700 Added 30.72%	20,000 $386,000
Q4 2017 Feb 14, 2018	BUY	$11.81 - $19.35 $180,693 - $296,055	15,300	15,300 $212,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.